title: Stability of trisodium citrate and gentamicin solution for catheter locks after storage in plastic syringes at room temperature.
abstract: BACKGROUND
  Catheter-related infections are a major problem for hemodialysis patients with central venous catheters for vascular access. Catheter lock solutions containing an anticoagulant are used to maintain the patency of the catheter between hemodialysis sessions. There is evidence that the use of lock solutions containing an antibiotic is associated with lower rates of infection but also that these solutions can kill microbes in colonized catheters and thus avoid the risks and costs associated with replacing the catheter.
  
  
  OBJECTIVE
  This stability study was conducted to determine whether an extemporaneously prepared gentamicin-citrate catheter lock solution would retain its potency over time, thus allowing for advance preparation of the solution.
  
  
  METHODS
  Catheter lock solutions containing gentamicin alone, citrate alone, and the combination of gentamicin and citrate were prepared aseptically and packaged in polyethylene syringes. The syringes were stored at room temperature. At timed intervals over 112 days, samples were withdrawn for analysis by means of validated high-performance liquid chromatography.
  
  
  RESULTS
  None of the 3 lock solutions showed any evidence of degradation during the 112-day observation period. In the formulation containing both gentamicin 2.5 mg/mL and sodium citrate 40 mg/mL (4%), there was no change in the concentration of either gentamicin (p = 0.34) or citrate (p = 0.55). Linear regression analysis of the concentration-time data for the combined formulation showed that 99.97% of the labelled amount of gentamicin and 101.30% of the labelled amount of citrate remained at day 112. The lower limit of the 95% confidence intervals indicated that more than 98.17% of the gentamicin and more than 99.57% of the citrate remained on day 112.
  
  
  CONCLUSIONS
  The results of this study will allow pharmacies to extemporaneously compound the combined gentamicin-citrate catheter lock solution in advance of use. The method described here will yield a stable product for use in clinical applications.
authors.affiliation: , BSc(Pharm), MSc, PhD, is an Instructor with the Faculty of Pharmacy, University of Manitoba, Winnipeg, Manitoba.
authors.forename: Dennis
authors.initials: D
authors.lastname: Cote
authors.forename: Charmaine E
authors.initials: CE
authors.lastname: Lok
authors.forename: Marisa
authors.initials: M
authors.lastname: Battistella
authors.forename: Lavern
authors.initials: L
authors.lastname: Vercaigne